Generic regulatory convergence project extended to more products
This article was originally published in Scrip
Executive Summary
The European Medicines Agency is to begin sharing its assessment reports on generic medicines with selected non-EU regulatory agencies as part of a drive to improve the efficiency of review processes and make it possible to synchronize marketing authorizations across different jurisdictions.
You may also be interested in...
MSF Wants Faster Deployment Of Ebola Vaccine At ‘Fair’ Price
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Drug Shortages, AMR & Cancer High On New EU Commissioner’s Agenda
The new EU commissioner for health has been given a number of high-priority tasks, including medicines supply and tackling antimicrobial resistance. These topics will be taken up by the European Commission’s advisory body, the Pharmaceutical Committee, in its new work plan.
EU Raises Pressure On Pharmaceutical Pollution Of The Environment
Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.
Need a specific report? 1000+ reports available
Buy Reports